Glucose (Viaflo) Baxter

Glucose (Viaflo) Baxter is an intravenous solution containing glucose as the sole active ingredient. It is supplied in a sterile liquid form for infusion, with the specific concentration not disclosed in the product label. Marketed in the European Union and available by prescription only, this preparation is used to provide an immediate source of carbohydrate energy and to act as an osmotic agent for fluid replacement.

Glucose (Viaflo) Baxter is indicated for clinical situations that require rapid carbohydrate supplementation or fluid balance restoration.

- Treatment of hypoglycemia in patients unable to take oral glucose. - Intravenous fluid and electrolyte replacement in dehydration or shock. - Support during surgical procedures to maintain blood glucose levels. - Management of metabolic disorders where glucose infusion is required.

When administered intravenously, Glucose (Viaflo) Baxter may be associated with a range of observed effects.

Common: - Transient rise in blood glucose levels. - Mild nausea or vomiting. - Local irritation or pain at the infusion site.

Serious: - Severe hyperglycemia with osmotic diuresis. - Allergic reactions including rash, itching, or anaphylaxis. - Fluid overload or pulmonary edema in patients with cardiac dysfunction.

Healthcare professionals should observe specific precautions when prescribing or administering Glucose (Viaflo) Baxter to ensure patient safety.

- Verify blood glucose levels before and during infusion. - Adjust infusion rate in patients with renal or cardiac impairment. - Use aseptic technique to prevent contamination. - Monitor electrolytes, especially sodium and potassium, during prolonged therapy. - Avoid rapid infusion in neonates and infants. - Assess for signs of fluid overload in susceptible individuals.

Glucose (Viaflo) Baxter can interact with certain medications, requiring attention to avoid adverse outcomes.

Avoid: - Co-administration with high-dose insulin without glucose monitoring. - Simultaneous infusion of hypertonic saline solutions that may exacerbate hyperglycemia. - Use with drugs that contain potassium in high concentrations without electrolyte monitoring.

Use with caution: - Concurrent use of diuretics that affect fluid balance. - Administration alongside corticosteroids that raise blood glucose. - Combination with beta‑adrenergic agonists that can increase glucose production.